about
T cell antigen processing and presentationantigen processing and presentation of peptide or polysaccharide antigen via MHC class IIantigen processing and presentation of endogenous antigenantigen processing and presentation of exogenous antigendendritic cell antigen processing and presentationantigen processing and presentation of peptide antigenB cell antigen processing and presentationantigen processing and presentation following pinocytosismonocyte antigen processing and presentationmacrophage antigen processing and presentationnon-professional antigen presenting cell antigen processing and presentationantigen processing and presentation via MHC class Ibantigen processing and presentation initiated by receptor mediated uptake of antigenantigen processing and presentation following phagocytosis
P279
Histocompatibility 2, class II antigen E alphaCD1d1 antigenFMS-like tyrosine kinase 3CD8a moleculeC-type lectin domain family 4 member MRELB proto-oncogene, NF-kB subunitHLA class II histocompatibility antigen, DM alpha chainMajor histocompatibility complex, class II, DM betaMajor histocompatibility complex, class II, DP beta 1Major histocompatibility complex, class II, DP alpha 1RAB4A, member RAS oncogene familyAdaptor related protein complex 3 subunit beta 1Adaptor related protein complex 3 subunit delta 1RAB33A, member RAS oncogene familyCathepsin HHLA class I histocompatibility antigen, A-1 alpha chainRAB5B, member RAS oncogene familyCD74 moleculeRAB6A, member RAS oncogene familyMajor histocompatibility complex, class II, DO alphaMajor histocompatibility complex, class II, DO betaRAB27A, member RAS oncogene familyMajor histocompatibility complex, class II, DR beta 1Major histocompatibility complex, class I, CHLA class II histocompatibility antigen, DRB1-16 beta chainMajor histocompatibility complex, class II, DQ alpha 2Major histocompatibility complex, class II, DQ alpha 1Major histocompatibility complex, class II, DQ beta 1Major histocompatibility complex, class II, DQ beta 2Major histocompatibility complex, class II, DR beta 3RAB35, member RAS oncogene familyProteasome 20S subunit beta 8Putative HLA class I histocompatibility antigen, alpha chain HRAB32, member RAS oncogene familyRAB10, member RAS oncogene familyRAB8B, member RAS oncogene familyRAB3B, member RAS oncogene familyRAB3C, member RAS oncogene familyHLA class II histocompatibility antigen, DQ beta 2 chainHLA class II histocompatibility antigen gamma chain
P682
Inhibitory p41 isoform of invariant chain and its potential target enzymes cathepsins L and H in distinct populations of macrophages in human lymph nodesAlternatively spliced mRNA encodes a secreted form of human CD8 alpha. Characterization of the human CD8 alpha geneThe GTPase Rab3b/3c-positive recycling vesicles are involved in cross-presentation in dendritic cellsCell biology of antigen processing in vitro and in vivo.MHC class Ib molecules bridge innate and acquired immunity.
P921
Q14891029-78E3C5EA-60C3-4597-BE45-79B2C53C8CB7Q21095635-8CC54548-00ED-4895-9611-05C900F44277Q21113105-AE4BCF96-9D5A-4E54-89AE-C2D5EEF04A09Q21418228-F3D8A547-FBFE-433E-BB94-90BE123A2C88Q21439815-80FB8105-8DE5-471D-B145-7E3FB4D93545Q22276630-A3E6E8DC-CD71-4B46-80A3-AEA82F265C09Q22311605-11E5786E-9B8D-45D7-9920-03517EB38C7CQ22311616-46BEA6F0-F881-4D9C-A587-D245B97968B8Q22311636-66A25735-0F56-4F69-9319-9CD55A67078BQ22311639-06129E3E-D214-4213-82DF-BFA8F2B2A802Q22311643-14892C5C-B85C-4C83-8E7D-0061B0852CD3Q22311646-BE567050-658D-4A6B-8AE3-DC91D61ED31CQ22311732-9C14083B-B9FC-4567-9656-308A8CA60873Q22311738-1E055A67-77F4-4A04-B3F2-550279EC8C39
P279
Q14904876-4B200E8C-0455-4EF9-8168-DC1DBC99D136Q14905534-09A330D0-6585-4677-BAE2-0236D2CDCD79Q14912405-26C323B2-20DD-4DD4-A381-BD61D9069B00Q21100581-C093432B-C1BB-4D70-B25D-E2D9D71CEC76Q21100841-2F0018F5-DC8F-43CC-A582-A76E028FE9AEQ21100854-C6CC29CE-19D2-4997-8337-D1ABA063003EQ21102605-A038E248-44CC-4708-9645-CDBE8357963FQ21102612-EA1C34F4-4418-4406-A56F-C5252F6C9BC8Q21102659-2B6ADF1B-CD5F-434C-9333-5C4975DA6B5EQ21102663-272E15B4-FF33-46E7-A164-4073D09B0F57Q21106139-CF230592-F1B4-4FD2-8CA3-DAE925DB5F46Q21106367-9D02873E-BD63-49D1-9744-33EC3839CEB3Q21106369-4958C776-9788-44A8-B1E4-79E80DF4DFC2Q21106477-CC165028-5903-477E-AD26-E6771F02D3A7Q21108330-36DC4548-7D2E-4254-BAB4-1486CD39B1CAQ21109237-E2317949-8887-415A-8393-98AAAC96C860Q21112280-72EFBE63-C9FA-431A-B1CB-14FB46F9DB90Q21113110-CB7E413A-BD5E-45C4-B677-A00820EDEBDEQ21113309-B95D008B-A2FD-4C74-AAC6-BBE4AF6C6AE2Q21114256-700B0F3B-8CF3-42BD-865D-01D7638F6AE3Q21114257-2D43B466-5706-45F3-B291-20AB42A06A44Q21114928-10CB23E4-F1CD-4117-B7F6-721217B57E63Q21114959-6EF0FFC0-4E17-44F2-8D2D-2287400D9CA4Q21114962-36BB4FB4-C044-4A10-8674-533E9B10AC81Q21115013-CD682A9D-FAD0-4CF1-B290-368106D48AF6Q21117989-F87FEDBD-0DEA-4C4E-A16D-BA85D4625006Q21117990-A82F5E8B-2CA2-445A-954B-F7F56D8D686BQ21117991-8FCDD9C5-4BDF-4F69-AA6A-CFF261702505Q21117992-D072B199-8ECA-4AE1-B35C-DCFCD3ABE34DQ21117998-F595F8A0-D5FE-483A-BB78-92137F64E204Q21119450-29FE492D-0274-440F-A225-F42976CB4A6CQ21119744-663C41C7-2FA3-40CA-97EA-3FBC5A898973Q21120611-6579D9F4-4B32-490A-9750-4CC7113D0BB8Q21121622-6BA6101F-22A9-4015-B8FF-67D645822672Q21123657-6D2C912A-4FAE-409E-8549-C8771969C296Q21126901-80A90541-3475-43FB-8DDB-51C1AEADF6B1Q21135210-50B40F5F-5166-474F-A655-F80674160A40Q21135247-CCBAE741-095E-4148-86A1-362DCC22008DQ21139155-040C0483-3FF2-42E1-A969-7A02FAAFECDAQ21150435-8B5071EA-AFBD-4CB6-83AC-AE4E8B8567E5
P682
description
The process in which an antige ...... n with an MHC protein complex.
@en
biologisch proces
@nl
name
antigen processing and presentation
@en
verwerking en presentatie van antigeen
@nl
type
label
antigen processing and presentation
@en
verwerking en presentatie van antigeen
@nl
altLabel
GO:0019882
@en
antigen presentation
@en
antigen processing
@en
prefLabel
antigen processing and presentation
@en
verwerking en presentatie van antigeen
@nl
P2888
P686
GO:0019882